Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:552-557

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penn, A.
Right arrow Articles by Snyder, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penn, A.
Right arrow Articles by Snyder, C. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*1,3-BUTADIENE
Medline Plus Health Information
*Secondhand Smoke

(Circulation. 1996;93:552-557.)
© 1996 American Heart Association, Inc.


Articles

1,3 Butadiene, a Vapor Phase Component of Environmental Tobacco Smoke, Accelerates Arteriosclerotic Plaque Development

Arthur Penn, PhD; Carroll A. Snyder, PhD

From the Nelson Institute of Environmental Medicine, New York University Medical Center, New York, NY.

Correspondence to Arthur Penn, PhD, Nelson Institute of Environmental Medicine, New York University Medical Center, Long Meadow Road, Tuxedo, NY 10987.

Background Our recent results support predictions from epidemiology studies that thousands of excess heart disease–related deaths result yearly in the United States from involuntary exposure to environmental tobacco smoke (ETS). Limited exposures of cockerels to ETS significantly accelerate arteriosclerosis. Despite little direct in vivo support, tar fraction rather than vapor phase compounds are considered largely responsible for the plaque-promoting effects of cigarette smoke. Here, we evaluate the effects of two ETS components on plaque development: the vapor phase component, 1,3 butadiene, and the tar component, the tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). At relatively high doses, injected NNK is carcinogenic in rodents. Epidemiology studies have identified increased mortality from arteriosclerotic heart disease among black men working in the butadiene rubber industry. Neither butadiene nor NNK has been tested experimentally for a possible role in plaque development.

Methods and Results Cockerels inhaled butadiene (20 ppm; 16 weeks) or were injected biweekly with NNK (10 mg/kg, 16 weeks). Control cockerels were exposed to filtered air or were injected with the NNK solvent dimethylsulfoxide. Plaque incidence, prevalence, location, and size were determined double-blind. NNK had no significant effect on any of these measurements. In contrast, butadiene elicited a statistically significant increase in plaque size comparable to that seen after steady-state exposure to ETS from 5 cigarettes.

Conclusions (1) This study represents the first time that a single cigarette smoke component has been demonstrated to accelerate arteriosclerosis, at a dose that is environmentally relevant. (2) The plaque-promoting components of ETS may reside in the vapor phase. (3) The cockerel model should be valuable in understanding the mechanism underlying the reported increases in heart disease deaths among black workers in the butadiene rubber industry.


Key Words: arteriosclerosis • butadiene • sidestream smoke




This article has been cited by other articles:


Home page
CirculationHome page
E. K. Tong and S. A. Glantz
Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease
Circulation, October 16, 2007; 116(16): 1845 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Witschi
Carcinogenic Activity of Cigarette Smoke Gas Phase and Its Modulation by Beta-Carotene and N-Acetylcysteine
Toxicol. Sci., March 1, 2005; 84(1): 81 - 87.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J.E. Sharman, J.R. Cockcroft, and J.S. Coombes
Cardiovascular implications of exposure to traffic air pollution during exercise
QJM, October 1, 2004; 97(10): 637 - 643.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Anazawa, P. C. Dimayuga, H. Li, S. Tani, J. Bradfield, K.-Y. Chyu, S. Kaul, P. K. Shah, and B. Cercek
Effect of Exposure to Cigarette Smoke on Carotid Artery Intimal Thickening: The Role of Inducible NO Synthase
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1652 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Bhatnagar
Cardiovascular pathophysiology of environmental pollutants
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H479 - H485.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. A. Glantz
Air pollution as a cause of heart disease: Time for action
J. Am. Coll. Cardiol., March 20, 2002; 39(6): 943 - 945.
[Full Text] [PDF]


Home page
FASEB J.Home page
M. H. WILSON, P. J. GRANT, L. J. HARDIE, and C. P. WILD
Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction
FASEB J, April 1, 2000; 14(5): 791 - 796.
[Abstract] [Full Text]


Home page
CirculationHome page
S. A. Glantz and W. W. Parmley
Passive and Active Smoking: A Problem for Adults
Circulation, August 15, 1996; 94(4): 596 - 598.
[Full Text]